Fact CheckerSign in

NCT05683418RecruitingPhase 1/2

First in Human Study of TOS-358 in Adults with Soid Tumors

Source: EU CTIS (euclinicaltrials.eu) · Last updated 21 Apr 2026

Status (registry)
Recruiting
Phase (registry)
Phase 1/2
Study type
Interventional
Enrollment
175 (estimated)
First submitted
3 Oct 2023
Start date
19 Feb 2024
Lead sponsor
Totus Medicines Inc.
NCT number
NCT05683418
EU CT number
2023-505346-26-01

What you commit to

  • Study type: Interventional · Phase 1/2
  • Planned participants: 175
  • 10 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study, not your situation.

Sites (10)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hospital HM Nou Delfos
Coordinator of this site? Confirm its status
BarcelonaSpainRecruiting
Vall d'Hebron Institute of Oncology
Coordinator of this site? Confirm its status
BarcelonaSpainRecruiting
Hospital Quirónsalud Barcelona
Coordinator of this site? Confirm its status
BarcelonaSpainRecruiting
Hospital Universitario HM Sanchinarro
Coordinator of this site? Confirm its status
MadridSpainRecruiting
Clinica Universidad de Navarra
Coordinator of this site? Confirm its status
MadridSpainRecruiting
Hospital Clínico San Carlos
Coordinator of this site? Confirm its status
MadridSpainRecruiting
Hospital Universitario Fundación Jiménez Díaz
Coordinator of this site? Confirm its status
MadridSpainRecruiting
Clínica Universidad de navarra
Coordinator of this site? Confirm its status
PamplonaSpainRecruiting
Hospital Universitario Quironsalud Madrid
Coordinator of this site? Confirm its status
Pozuelo de AlarcónSpainRecruiting
Hospital Clinico Universitario de Valencia
Coordinator of this site? Confirm its status
ValenciaSpainRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.